We present the clinical and laboratory features of a boy with a new syndrome of mitochondrial depletion syndrome and T cell immunodeficiency. The child suffered from severe recurrent infectious diseases, anemia, and thrombocytopenia. Clinically, he presented with severe psychomotor retardation, axial hypotonia, and a disturbed pain perception leading to debilitating biting of the thumb, lower lip, and tongue. Brain imaging showed hypoplasia of corpus callosum and an impaired myelinization of the temporooccipital region with consecutive supratentorial hydrocephalus. Histologic examination of a skeletal muscle biopsy was normal. Biochemical investigation showed combined deficiency of respiratory chain complexes IIϩIII and IV. MtDNA depletion was found by real-time PCR. No pathogenic mutations were identified in the TK2, SUCLA2, DGUOK, and ECGF1 genes. A heterozygous missense mutation was found in POLG1. The pathogenic relevance of this mutation is unclear. Interestingly, a lack of CD8 ϩ T lymphocytes as well as NK cells was also observed. The percentage of CD45RO-expressing cells was decreased in activated CD8 ϩ T lymphocytes. Activation of T lymphocytes via IL-2 was diminished. The occurrence of the immunologic deficiency in our patient with mtDNA depletion is a rare finding, implying that cells of the immune system might also be affected by mitochondrial disease. with clinical manifestations, which may be caused by mutations of nuclear DNA (nDNA) or mitochondrial DNA (mtDNA). Due to diverse genetic causes and occurrence in various developmental stages, tissues, or systems, there is a wide variability in clinical phenotype that spans all age groups (1). As many of the RC disorders involve brain and skeletal muscle, these disorders are also known as mitochondrial encephalomyopathies (2). Nevertheless, given the essential role of oxidative phosphorylation in tissue function, virtually all tissues and organs can be involved, accounting for a diverse array of multisystem disorders with a large variety of clinical symptoms in both childhood and adulthood.
M itochondrial diseases are a complex family of disorders
with clinical manifestations, which may be caused by mutations of nuclear DNA (nDNA) or mitochondrial DNA (mtDNA). Due to diverse genetic causes and occurrence in various developmental stages, tissues, or systems, there is a wide variability in clinical phenotype that spans all age groups (1) . As many of the RC disorders involve brain and skeletal muscle, these disorders are also known as mitochondrial encephalomyopathies (2) . Nevertheless, given the essential role of oxidative phosphorylation in tissue function, virtually all tissues and organs can be involved, accounting for a diverse array of multisystem disorders with a large variety of clinical symptoms in both childhood and adulthood.
MDS is defined as a reduction of mtDNA copy number compared with nDNA in different tissues, which leads to insufficient synthesis of RC complexes I, III, IV, and V (3). Autosomal recessive mutations of five nuclear genes have been identified in MDS patients with different clinical presentations (2,4 -7) . The onset of symptoms usually occurs during the first year of life and most patients die in early childhood. Thymidine phosphorylase (ECGF1) defects are associated with leukodystrophy and gastrointestinal disorders (8) . Mutations in deoxyguanosine kinase (DGUOK) (9) and polymerase gamma (POLG1) (10, 11) were described in the hepatocerebral form of MDS, whereas thymidine kinase 2 (TK2) mutations are associated with a mostly myopathic phenotype and CK elevation (12) . Most recently, mutations in the succinyl-CoA synthase (SUCLA2) were identified in four infants of a single family reported with severe psychomotor retardation, epilepsy, hearing loss, Leigh-like lesions on MRI, and anemia (13) . Mitochondrial depletion can affect single organs, typically skeletal muscle or liver, although in a later phase of the disease, multiple tissues are often involved (5) (6) (7) .
Childhood myelodysplasia occasionally occurs as the initial symptom of a mitochondrial disease (14) , and is usually associated with the Pearson's marrow-pancreas syndrome (15, 16) . This syndrome combines refractory anemia with ring sideroblasts and vacuolization of marrow precursors, and variable degrees of neutropenia and thrombocytopenia. We describe the clinical features of a child with a defect of the respiratory chain caused by mtDNA depletion with a unique T cell phenotype characterized by reduction in numbers of CD8 ϩ CD45RO ϩ T cells as well as of CD56 ϩ CD3 -NK cells, and impaired T cell maturation and activation. To our knowledge, this is the first report of immunodeficiency of specific lymphocyte subsets associated with mitochondrial disease.
PATIENTS AND METHODS
Case Report. The child was born at 39 wk of gestation to healthy, first-degree consanguineous parents. He had a healthy 1-y-old sister. At 16 wk of gestation, amniocentesis was performed following detection of hygroma colli on routine ultrasound examination. Levels of alpha-fetoprotein and acetylcholine esterase in amniotic fluid were normal, and chromosome analysis showed a normal male 46XY karyotype. The pregnancy was uneventful, and delivery was uncomplicated. At birth, he weighed 2610 g [ϽP10 (10 th percentile)], was 49 cm long (P25), and had a head circumference of 35.5 cm (P50). Apgar scores were 8/10/10, and the umbilical arterial pH was 7.23. Postnatal tachycardia and dyspnea with need for oxygen administration lead to transfer to neonatal intensive care unit. Polycythemia, requiring hemodilution, as well as thrombocytopenia, requiring repeated transfusion of platelet concentrates, were noted immediately after birth. Clinically and biochemically, there were no signs of associated infection. A maternal TORCH [congenital infection with toxoplasmosis, other, rubella, cytomegalovirus (CMV), herpes simplex virus (HSV)] infection was excluded.
Neurologic examination revealed adynamia, hypotonia of the trunk, complete absence of deep tendon reflexes as well as primitive reflexes (Moro, palmar, and plantar grasp), and a disturbed pain perception with complete absence of pain expression. Cranial ultrasonography showed hydrocephalus internus. MRI showed hypoplasia of the corpus callosum, and an impaired myelinization of the temporo-occipital region with consecutive supratentorial hydrocephalus. Nerve conduction velocity demonstrated normal motor nerves, but impaired sensory conduction with reduced amplitude, consistent with combined axonal and demyelinating neuropathy. Repeated somatosensory-evoked potentials of the N. medianus demonstrated a disruption of ponto-cerebral conduction, and brainstem auditory-evoked potentials showed progressive slowing of conduction after entering the brainstem, indicative of a functional problem in central nervous myelination. EEG were normal. Facial features included a high forehead, short philtrum, low-set, dysplastic ears, and short neck, and partial syndactyly of toes II and III was present ( Fig.  1) .
At age 5 d, he developed septicemia with maculopapular exanthema, paronychia, and conjunctivitis. Staphylococcus aureus was cultured from a throat swab. Lesions resolved with standard antibiotic treatment. The boy was hospitalized until the age of 3 mo for recurrent episodes of bloody diarrhea, as well as septicemia and significant thrombocytopenia. Stool and blood cultures failed to detect any infectious agent. Isolated germs were Klebsiella pneumoniae from a skin and nose swab, and Pantoea agglomerans from the central venous catheter. The child was treated with several courses of standard intravenous antibiotics. At 3 mo of age, a first episode of significant bleeding of the tongue and ulcerations of the oral mucosa were noted. A blood count revealed anemia and thrombocytopenia requiring repeated red blood cell and platelet transfusions. The child was discharged from hospital at 3 mo of age with a prophylactic antibiotic and antimycotic medication. In addition, he was put on intravenous immunoglobulin (IVIG) substitution every 4 wk for treatment of hypogammaglobulinemia (Table 2) .
Between the ages of 4 and 13 mo, the patient experienced six severe infectious episodes leading to hospitalization, three episodes of bloody gastroenteritis, three episodes of bronchopneumonia, and four episodes of septicemia, each with significant anemia and/or thrombocytopenia, requiring 12 erythrocyte and 6 platelet concentrate transfusions. Blood and stool cultures were repeatedly negative; the only germs isolated were S. aureus and Enterobacter cloacae from lesions of the thumb, Bacillus cereus and Pseudomonas aeruginosa from the eyes, E. cloacae from throat swabs, and S. epidermidis from an infected lymph node. The patient was frequently biting his thumb while sucking due to absent pain reaction, leading to progressive ulceration of the tongue and lip (Fig. 2) . Severe statomotor retardation was noted at age 9 mo, with development corresponding to 2-3 mo of age. A muscle biopsy was performed at 11 mo of age.
At 13 mo, the boy was hospitalized for anemia and progressive deterioration of his clinical condition. His weight, height, and head circumference were below the 3rd percentiles for age (weight, 6.1 kg, i.e. 2.6 kg Ͻ P3; length, 69.2 cm, i.e. 4 cm Ͻ P3; head circumference, 43.5 cm, i.e. 1.5 cm Ͻ P3). Abdominal ultrasonography showed progressive homogenous hepatosplenomegaly. Several erythrocyte transfusions were given in the following months while the clinical condition of the boy was deteriorating further. Treatment with carnitine, nicotinamide, alpha-lipoic acid, vitamin C, CoQ (coenzyme Q), vitamin E, zinc, and vitamin D was started after the diagnosis of RC disease. Death occurred at 18 mo during an episode of septicemia. The child was admitted to hospital with Cheyne's stokes respiration, dilated fixed pupils, centralized circulation, increased muscle tone, hemorrhagic conjunctivitis, and bloody diarrhea. Resuscitation was attempted but without success.
Mild hyperlactatemia was noted on several occasions (range, 2.6 -4.5 mM; norm Ͻ 2.5 mM). Extensive screening for metabolic disease was done, including pilocarpine iontophoresis, oral glucose tolerance test, acylcarnitine profile by tandem mass spectrometry, analysis of thyroid hormones, glucose-6-phosphate dehydrogenase, phenylalanine, galactose-1-phosphat-uridyltransferase, 17-OH progesterone, and biotinidase-activity, all of which were normal. A congenital disorder of glycosylation (CDG) was excluded by the presence of a normal isoelectric focusing of transferrins in serum. There was a normal pattern of amino acids in serum, and of organic acids as well as purine/pyrimidines in urine. There were no signs of cardiomyopathy, pancreatic dysfunction, or renal disease.
Written informed consent was obtained from the parents of the child. Morphology and biochemistry of skeletal muscle. Six-micrometer serial cross-sections of muscle biopsy specimens were obtained for histochemical stains according to standard procedures. A frozen part of the biopsy was used for biochemistry. The biopsy was kept at -80°C until analysis. RC complexes I-IV activities were determined in skeletal muscle as described (17) .
DNA analysis. DNA extraction from muscle, blood, and fibroblasts was done according to standard purification protocols (QIAGEN GmbH, Hilden, Germany). RFLP analysis of the frequent tRNA mutations and long-range PCR to detect mtDNA deletions were performed by standard methods. MtDNA and nDNA copy numbers and the mtDNA/nDNA ratio within tissues were determined by real-time PCR using a fluorescence temperature cycler (LightCycler, Roche Molecular Biochemicals, Mannheim, Germany). A LightCycler FastStart DNA Master SYBR Green I kit (Roche Molecular Biochemicals) was used with unlabeled primers as described (18) . All samples were run in triplicate. Sequencing of the nuclear-encoded TK2 (12), SUCLA2 (13), POLG1 (19) , DGUOK (9) , and ECGF1(8) genes was performed as previously described. POLG1 cDNA primers can be provided on request. For RFLP analysis for c.3559CϾT, the PCR product of exon 22 was digested with the restriction enzyme Age I.
Serological assays. Specific antibodies against tetanus toxoid and Haemophilus influenzae were routinely measured by ELISA (Progen Biotechnik, Heidelberg, Germany). IgA, IgG, and IgM were assayed by nephelometry (Dade Behring Holding, Liederbach, Germany), and IgG-subclasses were analyzed by turbidimetry (The Binding Site, Birmingham, UK). Serum antibodies to pneumococcal conjugate vaccine (PCV)-serotypes 6B, 14, 19F, and 23F and nonPCV-serotype 5 were determined before and 7 and 28 d after the PPV (pneumococcal polysaccharide vaccine) booster vaccination. Serotypespecific IgG-antibody concentration was measured by a modified ELISA technique using Nunc CovaLink microtiter plates (Nunc GmbH. Wiesbaden, Germany) and serum lot 89-SF as reference (Food and Drug Administration, Bethesda, MD). Serum samples were preincubated with 10 g/mL pneumococcal polysaccharide C (CPS, Statens Seruminstitut, Copenhagen, Denmark) for blocking of unspecific anti-CPS-antibodies. Reference serum 89-SF (kindly provided by Dr. C. Frash, Rockville, MD) was used for assay standardization. Sera with known high-antibody titers were used as reference and quality control sera (Endobulin HP, Immuno AG, Vienna, Austria) (20) . Minimum antibody detection level was 0.1 g/mL.
Immunophenotyping. Disease-associated immunophenotyping was assessed by four-color flow cytometric determination of T cell subsets, natural killer (NK) cells, and B cells in peripheral blood (PB) samples on a Coulter Epics XL (Beckman Coulter GmbH, Krefeld, Germany). Briefly, 100 L of PB were labeled for 20 min each with the 45/4/8/3 or 45/56/19/3 tetraChrome reagents (Coulter). In addition, naïve cells (
ϩ HLA-DR ϩ ) were detected. All antibodies were obtained from Coulter Immunotech (Marseille, France), labeled with the corresponding four different antibodies conjugated with FITC, phycoerythrin (PE), phycoerythrin-Texas Red (ECD), and phycoerythrin-cyanine 5.1 (PC-5). The percentage of lymphocytes determined in these analyses was used to calculate the absolute lymphocyte counts in a dual-platform approach (21) .
Cell stimulation and activation assay. Peripheral blood mononuclear cells (PBMC) were separated from heparinized whole blood by density gradient centrifugation on Ficoll-Hypaque and washed three times with RPMI 1640 medium. Cells were cultured in 96-well flat-bottom plates in RPMI 1640 medium supplemented with 10% FCS, 1% penicillin/streptomycin, 1% HEPES, 2% glutamine, and 0.2% gentamicin at a concentration of 1 ϫ 10 6 cells/mL. For induction of cell activation markers and proliferation, lymphocytes were incubated for 72 h in the presence of phytohemagglutinin (PHA)
(1 mg/mL), IL-2 (100U/mL), and/or phorbol-12,13-dibutyrate (PBu2, 1 ng/ mL) in conjunction with ionomycin (0.5 mg/mL). Before and after stimulation, immunophenotyping was used to determine the appropriate lymphocyte subset population as described above.
Cell proliferation. The rates of DNA synthesis were assayed by measuring [3H]thymidine incorporation into PBMC. Cells were pulsed with [3H]thymidine (1.0 Ci/mL) over the last 18 h of the 72-h incubation period and the incorporated radioactivity was measured by scintillation counting.
RESULTS
Morphology and biochemistry of skeletal muscle. Histologic investigation of skeletal muscle showed a normal muscle structure, no ragged red fibers, and normal succinate dehydrogenase (SDH) staining, but a generalized deficiency of the stain for cytochrome c oxidase (COX). Biochemical measurements of the respiratory chain enzymes showed combined deficiency of the complexes IIϩIII and IV, related to both g NCP, and the mitochondrial marker enzyme citrate synthase (CS) ( Table 1) , whereas activity of complex I was normal. Complex II activity was not measured because of lack of muscle material. The nuclear encoded pyruvate dehydrogenase as well as citrate synthase had normal enzymatic activity. These findings are consistent with mtDNA depletion, and provide indirect evidence of normal SDH function. The activity of the complex IV in fibroblasts was normal.
DNA analysis. Screening of the muscle DNA with RFLP for the common tRNA mutations MELAS (mitochondrial myopathy, encephalopathy, lactacidosis, stroke) 3243, MERRF (myoclonic epilepsy and ragged red fiber disease) 8344, LEIGH/NARP (neuropathy, ataxia and retinitis pigmentosa) 8993G/C did not show any mutations. Long-range PCR excluded mtDNA deletions. Real-time PCR analysis of the patient's muscle DNA revealed a significant depletion of mtDNA. The mtDNA/nDNA ratio was 0.05 (normal range, 0.5-5.0), 10% of the lowest level found in control muscle DNA samples. Fibroblast DNA of the patient showed less severe, but also significant mtDNA depletion (mtDNA/nDNA ratio, 0.16; normal range, 0.5-2.5). Sequence analysis of the (Tables 2 and 3 ). The karyotype was 46XY with a normal chromosomal breakage rate. The thymus was of normal size. A bone marrow aspirate at the age of 3 wk showed a low megacaryocyte count with reduced but morphologically normal erythropoiesis. In particular, there were no sideroblasts or vacuolization of marrow precursors. Peripheral red blood cells were slightly hypochromic and microcytic, and reticulocyte counts were normal for age. Alloimmune thrombocytopenia and Wiskott-Aldrich syndrome were excluded. A search for parvovirus B19, CMV, HHV-6 in the bone marrow aspirate was negative. HIV1 and 2 infections were excluded. Septic granulomatosis was excluded by normal H 2 O 2 production, leucocyte adhesion deficiency (LAD) type 1 was excluded by normal expression of CD11a-c and CD18, and ZAP (zeta associated protein)-70 cDNA sequence was normal. HoyeraalHreidarsson syndrome was excluded by normal DKC1 (dyskeratosis congenital 1, dyskerin) gene. There were no clinical or biologic signs of allergy. There was no pattern of skewed X-inactivation of the HUMARA (X-linked human androgen receptor) locus in the patient's mother.
Humoral immunodeficiency. Serum Ig levels were low for age despite regular IVIG substitution. IgG1 and IgG2 subclasses were also low for age; IgG3 and IgG4 were normal. Titers of antibodies against polysaccharide antigens, such as blood isohemagglutinin A (titers 1:2 at room temperature, 1:16 at indirect Coombs' test), and serum antibodies against S. pneumoniae were low, despite repeated vaccination. In contrast, titers of antibodies against protein antigens such as tetanus toxoid and H. influenzae were normal (Table 2) .
Immuno phenotyping. The total number and morphology of lymphocytes and polymorphonuclear cells were initially normal (Table 3 ). There was a progressive decline in absolute lymphocyte numbers, especially of CD8 ϩ CD3 ϩ T cells and CD56 ϩ CD3 -NK cells, which was first noted at age 19 d. After 1 mo, the number of B cells as well as CD3 ϩ CD4 ϩ cells decreased. The number of CD8 ϩ CD3 ϩ T cells and CD56 ϩ CD3 -NK cells remained low. Expression of the memory marker CD45RO was low on CD8 ϩ T cells, whereas it was normally expressed on CD4 ϩ T cells. T cell proliferation and activation. Proliferative responses (Fig. 3 ) and cell activation (Fig. 4, A and B) to mitogens were normal in isolated PBMC. HLA-DR expression was slightly increased in PHA stimulated CD3 ϩ CD4 ϩ cells (Fig. 4C ), but normal in CD3 ϩ CD8 ϩ cells (Fig. 4D) . In contrast, activation via IL-2 was impaired in CD3 ϩ CD4 ϩ cells (Fig. 4A ) as well as in CD3 ϩ CD8 ϩ cells (Fig. 4B) , as measured by expression of CD69. Additionally, after in vitro stimulation with phorbol ester, the percentage of CD45RO ϩ
CD8
ϩ T lymphocytes was decreased (Fig. 5) .
DISCUSSION
We provide here a comprehensive clinical description of a child with an unknown syndrome of a mitochondrial disorder and T cell immunodeficiency. The patient presented with a unique severe phenotype, combining neurologic, hematoimmunologic, gastrointestinal, and skeletal muscle abnormalities. There were no signs of cardiac muscle abnormalities, endocrine, renal, or pancreatic involvement. The onset of the disease was very early, with no symptom-free period, suggesting antenatal expression of the disease. CNS involvement has been described in a few patients and includes corpus callosum agenesis or hypoplasia, porencephalic cysts, and enlarged cerebral ventricles (22) , all of which were present in our patient. The craniofacial anomalies noted in the child have 324 also been reported in other cases of RC deficiency (23) . Malformation during embryogenesis might be either due to a lack of ATP or the alteration of an apoptotic event controlled by the mitochondrial machinery (24) . Trunk hypotonia, hyporeflexia, peripheral neuropathy, statomotor retardation, and abnormal eye movements are common findings in other mitochondrial disorders (16) . Gastrointestinal presentation of the disease was marked by severe chronic diarrhea with failure to thrive. In our patient, diarrhea was almost exclusively associated with septic episodes and accompanied by severe transfusion-dependent anemia.
In addition, the patient suffered from early severe and recurrent anemia and thrombocytopenia. Myelodysplasia has been described in patients with Pearson's marrow pancreas syndrome (15, 25) , which was ruled out in our patient by morphologically normal erythropoiesis, the absence of sideroblasts or vacuolization of marrow precursors, and by the absence of mtDNA deletion on long-range PCR. Other RC deficiencies associated with anemia are NDUFS1 (a nuclearencoded Fe-S subunit of complex 1) (26), COXI (27) , and COX10 (28), as well as SUCLA2 (13) mutations. However, none of these diseases are associated with immunodeficiency. Similar to the effect of the single deletion in blood cells in Pearson's marrow pancreas syndrome, mtDNA depletion might lead to anemia and thrombocytopenia. With real-time PCR, a significantly reduced mtDNA/nDNA ratio was detected in both muscle and fibroblast DNA of the patient, indicating the diagnosis of MDS. Involvement of immunologically active cells has so far not been described in association with mtDNA depletion. Unfortunately, the diagnosis of mtDNA depletion in the patient was post mortem. We could not perform mtDNA depletion studies in these tissues, however, we suggest that the mtDNA depletion in lymphocytes led to immunodeficiency in this case.
Pathogenic mutations in four of the five nuclear genes (TK2, SUCLA2, DGUOK, ECGF1) described in association with mtDNA depletion were excluded in our patient. A heterozygous base pair exchange, c.3559CϾT was found in POLG1, causing an amino acid exchange on protein level. However, we believe that the heterozygous c.3559CϾT mutation is not related to the disease phenotype for the following reasons: Arginine is poorly conserved at position 1187 in the C terminal part of the protein, within the polymerase domain, next to previously described pathogenic mutations (S1176L, D1184N), as well as polymorphisms (E1143G, R1146C, Q1236H). The severe early-onset phenotype and the depletion of mtDNA suggest an autosomal recessive disease and no second mutation was detected in both POLG1 DNA and cDNA. The consanguinity of the parents would also suggest an autosomal recessive disease but with a homoplasmic mutation. Although clinical symptoms of the patient might be partly compatible with POLG1 deficiency (muscular hypotonia, gastrointestinal symptoms, hepatopathy), the most important clinical hallmark of a POLG1-related mtDNA depletion syndrome, progressive epileptic activity, was excluded by normal EEG.
Immunodeficiency was first suspected on the basis of multiple clinical infectious diseases presented by the patient. He ϩ CD4 ϩ (□) and CD3 ϩ CD8 ϩ () T cell subsets. PBMC were stimulated with PBu 2 (1 ng/mL) and ionomycin (0.5 mg/mL) for 96 h. Expression of CD45RO was measured by flow cytometry.
had numerous infections attributable to bacteria (Gramnegative bacilli, Gram-positive cocci) and fungi. No viral diseases were documented, suggesting that viral immunity was not significantly affected. The child had low serum Ig levels and did not produce antibodies specific for polysaccharide antigens. T and B cell responses to protein antigens and mitogens appeared normal except that serum Ig levels were low. The most striking immunologic phenotype was an early and persistent lack of CD8 ϩ T cells and CD56 ϩ CD3 -NK cells. The remaining CD8
ϩ T cells had a unique phenotype with a severely impaired expression of the memory marker CD45RO after activation of cells. To our knowledge, there are no reports on immunodeficiency of specific lymphocyte subsets associated with mitochondrial diseases. Whether the immune defect is directly related to the mitochondrial depletion or whether this association is coincidental in our patient is not certain. It raises the question of whether involvement of the immune system in MDS needs to be considered. Future goals include understanding how the defective proteins perturb replication, why MDS affects only some tissues and spares others, and which other genes should be considered in patients with mtDNA depletion.
